← Back
Research Paper Volume 14, Issue 11 pp 4673—4698

CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma

class="figure-viewer-img"

Figure 9. A schematic model of CXCR4 contributes distinctively to PI3K/Akt/mTOR pathway effects in EOC.